Beatrix Feigl Selected Research

melanopsin

1/2021	Melanopsin hypersensitivity dominates interictal photophobia in migraine.
4/2020	Rhodopsin and melanopsin contributions to human brightness estimation.
1/2020	Melanopsin Cell Dysfunction is Involved in Sleep Disruption in Parkinson's Disease.
11/2019	The melanopsin-directed white noise electroretinogram (wnERG).
9/2019	The flicker Pupil Light Response (fPLR).
1/2019	Outer Retinal Structure and Function Deficits Contribute to Circadian Disruption in Patients With Type 2 Diabetes.
1/2018	Melanopsin-mediated pupil function is impaired in Parkinson's disease.
1/2018	Melanopsin-Driven Pupil Response and Light Exposure in Non-seasonal Major Depressive Disorder.
1/2016	Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma.
12/2015	Effect of Age and Refractive Error on the Melanopsin Mediated Post-Illumination Pupil Response (PIPR).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beatrix Feigl Research Topics

Disease

7	Macular Degeneration (Age-Related Maculopathy) 10/2015 - 11/2005
5	Ganglion Cysts (Ganglion) 04/2020 - 05/2010
3	Glaucoma 01/2016 - 06/2011
3	Retinal Diseases 08/2014 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2018
2	Optic Nerve Diseases (Optic Neuropathy) 12/2015 - 08/2014
2	Hypoxia (Hypoxemia) 03/2011 - 02/2008
1	Migraine Disorders (Migraine) 01/2021
1	Photophobia (Light Sensitivity) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Retinal Degeneration 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Refractive Errors (Refractive Error) 12/2015
1	Disease Progression 10/2015
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 08/2014
1	Neoplasms (Cancer) 07/2013
1	Osteoarthritis 07/2013
1	Amblyopia (Lazy Eye) 03/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2012
1	Eye Diseases (Eye Disease) 05/2010
1	Ischemia 12/2005

Drug/Important Bio-Agent (IBA)

15	melanopsinIBA 01/2021 - 05/2010
13	Retinaldehyde (Retinal)IBA 01/2020 - 11/2005
2	Macular PigmentIBA 01/2014 - 11/2012
2	Indicators and Reagents (Reagents)IBA 06/2011 - 03/2011
2	Oxygen (Dioxygen)IBA 03/2011 - 02/2008
1	MelatoninIBA 01/2020
1	Rhodopsin (Visual Purple)IBA 09/2019
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Carotenoids (Carotene)IBA 01/2014
1	AntioxidantsIBA 01/2014
1	Biocompatible Materials (Biomaterials)IBA 07/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	Ranibizumab (Lucentis)FDA Link 06/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2005

Therapy/Procedure

1	Phototherapy (Light Therapy) 01/2020
1	Therapeutics 01/2019
1	Lasers (Laser) 11/2005
1	Photochemotherapy (Photodynamic Therapy) 11/2005